Today, the American Diabetes Association® (ADA) released a guidance statement on the use of compounded GLP-1 RA (glucagon-like peptide-1
Published: Monday, December 2, 2024
Give Today and Change lives!
With your support, the American Diabetes Association® can continue our lifesaving work to make breakthroughs in research and provide people with the resources they need to fight diabetes.